A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...
6h
StudyFinds on MSNPersonalized vaccines halt kidney cancer after encouraging phase 1 trialIn a nutshell Researchers developed personalized cancer vaccines for nine high-risk kidney cancer patients, with all participants remaining cancer-free after nearly three years of follow-up – a ...
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...
Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results